top of page

Tumor immunoregulation and drug sensitivity 

The research at a glance

Our research aims to improve cancer treatment. We study the response of tumors to the immune system and to targeted therapy, as well as mechanisms to promote immune cells’ capacity to recognize and eliminate malignant cells.

Main topics

Development of a Drug sensitivity
platform utilizing malignant pleural
effusion- derived tumor cells for
personalized cancer treatment

Proteomics of the Immunological
synapse and of the tumor
secretome to identify novel immunoregulators

הורדה.jpg
הורדה (1).png
GREEN_3193_04222021_0757.jpg
alk_peptide.tif

Mooshayef N, Barhom H, Chatterji S, Hecht N, Warhaftig O, Kamer I, Zadok O, Bar J, Broday L, Onn A, Peled M. Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing.
Molecular Oncology, 2025

The Center for Diagnostic Onco-pharmacology 

 Research support

isf_logo_edited_edited_edited.jpg
1248px-The_Israel_Cancer_Association_Log.webp
famri.jpg
רשות החדשנות.jpg

Latest publication

synapses_647.jpg

CONTACT US

cc6aee67-ee9d-4c3e-b496-93fe85561e3c.png

Are you a student who wants to join our team? A scientist who wants to collaborate? 

Contact us!

  • Black LinkedIn Icon

Thanks for submitting!

Sheba Medical Center,Ramat Gan, Israel

Contact

© 2023 by Tel Aviv University. Proudly created with Wix.com

bottom of page